Restor3d Secures $104M Funding to Scale Personalized 3D-Printed Orthopedic Implants Ahead of IPO

Aug 26, 2025 14:16 CST Updated 14:16

Restor3d

3D Printing Implant Supplier

Source of the article: Bone Future

Reprint Requirements: You can directly repost, please credit the source at the beginning of the article.

Audience Registration:The 3rd Global Surgical Robotics Conference

Guest and Audience Registration:2025 Medical Device R&D Innovation Forum (Shanghai)

August 22, 2025, U.S. Orthopedic 3D Printing CompanyRestor3dAnnouncement of Completion$104 million financing (approximately RMB 740 million)Led by Partners Group, with additional investment from existing shareholders. This marks the company's first introduction of global top-tier institutional capital.

In the cooling financing environment of 2025, such an amount is very rare. For investors, betting on Restor3d is not only about valuing the technology but also aboutThe Possibility of Personalized Orthopedic Implants Moving from Concept to Scale。

# From Lab to Operating Room: The Product Logic of Restor3d

Restor3d, Inc. was founded in 2017, originating from a laboratory at Duke University in the United States. Unlike traditional orthopedic companies, it chose a seemingly "narrow gate" direction from the very beginning——Personalized Orthopedic Implants。

Veritas Reverse Shoulder System: A Revolution in Efficiency

Shoulder surgery is known for its complex procedures and limited field of view. The Veritas system compresses what originally required an entire cart of instrument trays into...A tray. In the operating room, doctors no longer need to frequently change or search for instruments, significantly reducing preparation and operation time. More importantly, the system uses Restor3d's self-developed TIDAL porous structure, which promotes bone integration and long-term stability, and is currently advancing through FDA approval.

iTotal Identity Total Knee System: Breaking Free from the Constraints of "Bone Cement"

In April 2025, Restor3d's iTotal Identity Total Knee System received FDA approval. This isThe World's First Fully CementlessThe personalized knee replacement system. Traditional bone cement can age and loosen over time, while this new design relies on the patient's own bone integration to secure it, reducing long-term risks. Surgeons at the Florida Orthopaedic Institute commented: "This joint makes the knee feel more like 'regaining nature' rather than just a simple replacement."

Kinos Ankle System: More Options for Doctors

By acquiring Kinos Medical, Restor3d has incorporated ankle joints into its product portfolio. The Kinos system features a modular design, enabling surgeons to select different motion interfaces during surgery based on the patient’s soft tissue conditions. This flexibility enhances intraoperative decision-making freedom. The Aeros Modular Stem version, launched this year, further advances this capability.Reduce the number of instrument trays from 8 to 3, greatly simplifying the surgical procedure.

Velora Acetabular System: The Future Potential

The Velora Acetabular System focuses on the hip joint, still centered around the TIDAL structure, and is currently in the FDA approval stage. Its design concept is "long-term integration," aiming to make artificial joints more stable as a part of the body.

From shoulder, knee, ankle to hip, Restor3d has built a complete joint product matrix. Their common features are:More fitted, more efficient, more natural. These keywords are the core value of personalized implants.

# Clinical Value: Beyond "Customization" to Transforming Experience

In the operating room, time and compatibility often determine the success or failure of a surgery.

For doctors, the significance of personalization is primarilyEfficiencyVeritas Single Tray System Reduces Shoulder Surgery TimeMore than 20%The Kinos system reduces the number of trays, lightening the load on the nursing team. Doctors no longer need to make numerous temporary adjustments during surgery but can "use it right out of the box."

For patients, the value of personalization lies inRecovery More NaturalTaking iTotal Identity as an example, it is custom-designed based on the patient's bone structure, maintaining the original axis of rotation and mechanical distribution, making postoperative movement closer to that of a natural knee joint. For many patients who have long suffered discomfort, this not only improves function but also enhances quality of life.

For hospitals and the medical insurance system,Efficiency + Satisfaction ImprovementThis will ultimately lead to lower complication rates, faster recovery speeds, and higher resource utilization. It is also why an increasing number of doctors are willing to try these new solutions.

In a nutshell: Personalized implants are no longer "high-end customization," butA "Win-Win-Win" Solution Benefiting Doctors, Patients, and Hospitals Simultaneously。

# Capital Logic: Partners Group's "Long-Term Bet"

Why Would Partners Group Double Down on Restor3d in the Capital-Cooling 2025?

Long-termist investors

Partners Group, a Swiss-based private equity giant managing over $150 billion in assets, is known for its investment approach of "long-term partnership + deep involvement," often helping companies implement strategies by joining their boards. In this investment, they not only provide funding but also join the board of Restor3d, which means they will participate in future strategic directions.

Three Levels of Consideration in Investment Logic

Demand Certainty: The global volume of hip and knee replacements is still4-5% annuallyThe speed of growth, the trend of population aging is clear.
Technical Inflection Point: The efficiency improvement of 3D printing and the automation of AI design have made personalization scalable for the first time.
Competitive Landscape: Giant companies, although exploring personalization, are constrained by their existing product structures and are cautious in transitioning; Restor3d, unburdened, is more flexible.

What Partners Group saw was not the innovation of a small company, but the possibility that personalization could become the mainstream solution for the orthopedics industry in the next decade.

# Industry Observation: The Change in Personalized Orthopedics

International Trends

The orthopedic industry has long relied on "standardization + scale," but as patient expectations increase, this logic is being challenged. Whether it’s emerging companies like Restor3d and Conformis, or Stryker's personalized modules added to the Mako robot, the direction points towards "differentiation."

Technical Tipping Point

The efficiency of 3D printing metal forming has improved, and the cost has decreased;
AI automation modeling significantly shortens delivery time;
Digital surgical planning makes it easier for doctors to accept.

These factors are making personalization move gradually from a "luxury option" to the mainstream.

Insights from the Chinese Market

In China, there are also companies exploring 3D printing personalization, but there are many practical challenges:

Payment Not Covered: Most personalized products have not yet been included in medical insurance;
Insufficient Standardization: There is a lack of unified standards from image acquisition to modeling;
Doctor's Habits: It will take time for clinical use to be fully integrated.

This means that in order to achieve scale in China, efforts must be made simultaneously in policy, payment, and industry chain collaboration.

# Bone Future Observation: The "Tipping Point" from Niche to Mainstream

Restor3d's financing story essentially reflects a tipping point in the orthopedic industry:Can personalization truly move from niche to mainstream?

It gives three insights:

Technically, the integration of AI and 3D printing has proven that personalization is not out of reach;
Clinically, the actual experiences of doctors and patients make the value more convincing;
Capital-wiseThe entry of long-term capital has provided a guarantee for enterprises to overcome the expansion period.

But challenges remain: payment, standards, and physician education are all critical factors in determining whether personalization can become widespread.

In the next decade, the core competitive point in the orthopedic industry may no longer be about who can produce more "standardized products," but rather who can truly build a scalable, affordable, and implementable system for "personalization."

Restor3d is taking a crucial step along this path.

Recent Innovation Trends:Portable Bone Healing Device Biodegradable Zinc Alloy Interface Screws

Bioabsorbable Magnesium Alloy Compression Screw Shoulder Joint Planning Application Thoracolumbar Posterior Internal Fixation Magnetic Control Connecting Rod System

Recent Clinical Trends:Orthopedic Surgery Moves Toward Outpatient Care Robots Assist in Day Surgery

Recent Character Dynamics:Zimmer Biomet Executive Changes

SiYu Annual Event Review:The First Global Orthopedics Conference

Coming Soon:September 4-5, 2025, The 3rd Global Surgical Robotics Conference